For research use only. No human or veterinary administration.

Lyophilized powder development & OEM

Discuss freeze-dried research materials, fill targets, container closure and packaging development.

Research-use-only packaging concept
Illustrative packaging. Actual specifications require project review.

Match the dried form to the actual material

Lyophilization is a development choice, not a universal guarantee of stability, sterility or biological activity. A useful project brief identifies the material, the reason for drying it, the intended laboratory workflow and the attributes that must remain acceptable after processing. Those attributes may include appearance, residual moisture, content, relevant impurities and container closure performance. The appropriate tests depend on the substance and application.

Packaging development should consider light exposure, moisture sensitivity, handling frequency and the proposed transport route. A visually attractive powder cake cannot substitute for analytical release criteria. The vial images on this website illustrate packaging possibilities; the actual material, quantity and specification are confirmed separately. Send your technical objectives and sample evaluation plan so the team can identify what needs to be established before a pilot or bulk project. No clinical suitability is implied by a freeze-dried presentation.

  • Material identity and drying objective
  • Target fill basis: active content or total solids
  • Container, closure, label and carton requirements
  • Proposed moisture and stability acceptance criteria
  • Sample evaluation plan before production approval

Frequently asked questions

Does freeze-drying prove that CBL-514 is a peptide?

No. Lyophilization describes a drying process, not a molecular class. A powder's identity must come from its specification and analytical evidence, regardless of the physical form or container.

What should a 10 mg vial specification define?

Define whether 10 mg refers to active content, total dry mass or another agreed basis. Include material identity, fill tolerance, container, closure and analytical requirements; a label number alone is incomplete.

Can I request a 50 mg research-vial format?

A 50 mg target can be included in a development brief. The review must consider the material, quantity basis, vial capacity, processing and acceptance criteria before the format is agreed.

What is needed before quoting a 100 mg vial?

Provide material identity, intended laboratory use, quantity basis, total number of vials, packaging requirements and test scope. The nominal fill does not establish the formulation or an available batch.